相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。S-Adenosyl Methionine: A Natural Therapeutic Agent Effective Against Multiple Hallmarks and Risk Factors Associated with Alzheimer's Disease
Thomas B. Shea et al.
JOURNAL OF ALZHEIMERS DISEASE (2017)
Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses
Jerome Sarris et al.
AMERICAN JOURNAL OF PSYCHIATRY (2016)
Cognitive remission: a novel objective for the treatment of major depression?
Beatrice Bortolato et al.
BMC MEDICINE (2016)
Epigenetic RELN Dysfunction in Schizophrenia and Related Neuropsychiatric Disorders
Alessandro Guidotti et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines
Anthony Cleare et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2015)
Is S-Adenosyl Methionine (SAMe) for Depression Only Effective in Males? A Re-Analysis of Data from a Randomized Clinical Trial
J. Sarris et al.
PHARMACOPSYCHIATRY (2015)
Relationship between the catechol-O-methyl transferase Va1108/158Met genotype and brain volume in treatment-naive major depressive disorder: Voxel-based morphometry analysis
Keita Watanabe et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2015)
Role of betaine in improving the antidepressant effect of S-adenosyl-methionine in patients with mild-to-moderate depression
Francesco Di Pierro et al.
JOURNAL OF MULTIDISCIPLINARY HEALTHCARE (2015)
Complementary and alternative medicine therapies for perinatal depression
Kristina M. Deligiannidis et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2014)
S-adenosyl methionine (SAMe) versus escitalopram and placebo in major depression RCT: Efficacy and effects of histamine and carnitine as moderators of response
Jerome Sarris et al.
JOURNAL OF AFFECTIVE DISORDERS (2014)
A Double-Blind, Randomized, Placebo-Controlled Clinical Trial of S-Adenosyl-l-Methionine (SAMe) Versus Escitalopram in Major Depressive Disorder
David Mischoulon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2014)
Oral SAMe in Persistent Treatment-Refractory Bipolar Depression A Double-Blind, Randomized Clinical Trial
Beth L. Murphy et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2014)
A systematic review and meta-analysis of the evidence base for add-on treatment for patients with major depressive disorder who have not responded to antidepressant treatment: A European perspective
Pauline Turner et al.
JOURNAL OF PSYCHOPHARMACOLOGY (2014)
S-adenosylmethionine mediates inhibition of inflammatory response and changes in DNA methylation in human macrophages
Anna C. Pfalzer et al.
PHYSIOLOGICAL GENOMICS (2014)
Quantitative Evaluation of the Clinical Effects of S-Adenosylmethionine on Mood and Behavior in Lesch-Nyhan Patients
Diego Dolcetta et al.
NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS (2013)
Folate, Vitamin B12, and S-Adenosylmethionine
Teodoro Bottiglieri
PSYCHIATRIC CLINICS OF NORTH AMERICA (2013)
Current status and future prospects for epigenetic psychopharmacology
Marco P. Boks et al.
EPIGENETICS (2012)
Characterization of the neuropsychological phenotype of glycine N-methyltransferase-/- mice and evaluation of its responses to clozapine and sarcosine treatments
Ching-Ping Yang et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2012)
Effects of S-adenosylmethionine augmentation of serotonin-reuptake inhibitor antidepressants on cognitive symptoms of major depressive disorder
Yechiel Levkovitz et al.
JOURNAL OF AFFECTIVE DISORDERS (2012)
Role of epigenetics in pharmacotherapy, psychotherapy and nutritional management of mental disorders
J. Peedicayil
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2012)
Bioavailability of S-Adenosyl Methionine and Impact on Response in a Randomized, Double-Blind, Placebo-Controlled Trial in Major Depressive Disorder
David Mischoulon et al.
JOURNAL OF CLINICAL PSYCHIATRY (2012)
Suicide Attempt by Self-Burning Associated With Ingestion of S-adenosylmethionine A Review of the Literature and Case Report
Harvey Chitiva et al.
JOURNAL OF NERVOUS AND MENTAL DISEASE (2012)
The feasibility and safety of S-adenosyl-l-methionine (SAMe) for the treatment of neuropsychiatric symptoms in 22q11.2 deletion syndrome: a double-blind placebo-controlled trial
Tamar Green et al.
JOURNAL OF NEURAL TRANSMISSION (2012)
The Amyloid Precursor Protein (APP) Family Members are Key Players in S-adenosylmethionine Formation by MAT2A and Modify BACE1 and PSEN1 Gene Expression-Relevance for Alzheimer's Disease
Andreas Schroetter et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Relationships among biomarkers of one-carbon metabolism
Will D. King et al.
MOLECULAR BIOLOGY REPORTS (2012)
Serotonin-Induced Hypersensitivity via Inhibition of Catechol O-Methyltransferase Activity
Douglas Tsao et al.
MOLECULAR PAIN (2012)
COMT Val158Met polymorphism interacts with stressful life events and parental warmth to influence decision making
Qinghua He et al.
SCIENTIFIC REPORTS (2012)
Role of a redox-based methylation switch in mRNA life cycle (pre- and post-transcriptional maturation) and protein turnover: implications in neurological disorders
Malav S. Trivedi et al.
FRONTIERS IN NEUROSCIENCE (2012)
S-Adenosylmethionine Decreases Lipopolysaccharide-Induced Phosphodiesterase 4B2 and Attenuates Tumor Necrosis Factor Expression via cAMP/Protein Kinase A Pathway
Leila Gobejishvili et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2011)
Structural Mechanism of S-Adenosyl Methionine Binding to Catechol O-Methyltransferase
Douglas Tsao et al.
PLOS ONE (2011)
S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial
George I. Papakostas et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
A vitamin/nutriceutical formulation improves memory and cognitive performance in community-dwelling adults without dementia
A. Chan et al.
JOURNAL OF NUTRITION HEALTH & AGING (2010)
Cytokines and Glucocorticoid Receptor Signaling Relevance to Major Depression
Thaddeus W. W. Pace et al.
GLUCOCORTICOIDS AND MOOD CLINICAL MANIFESTATIONS, RISK FACTORS, AND MOLECULAR MECHANISMS (2009)
Improvement of aggressive behavior and quality of life impairment following S-Adenosyl-Methionine (SAM-e) augmentation in schizophrenia
Rael D. Strous et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2009)
Dietary Supplement S-Adenosyl-L-Methionine (AdoMet) Effects on Plasma Homocysteine Levels in Healthy Human Subjects: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Michael A. Thompson et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2009)
A metabolic link between S-adenosylhomocysteine and polyunsaturated fatty acid metabolism in Alzheimer's disease
Michael L. Selley
NEUROBIOLOGY OF AGING (2007)
S-adenosyl methionine and DNA methyltransferase-I mRNA overexpression in psychosis
Alessandro Guidotti et al.
NEUROREPORT (2007)
Dramatic reduction in self-injury in Lesch-Nyhan disease following S-adenosylmethionine administration
Norris Glick
JOURNAL OF INHERITED METABOLIC DISEASE (2006)
S-adenosylmethionine:: jack of all trades and master of everything?
WAM Loenen
BIOCHEMICAL SOCIETY TRANSACTIONS (2006)
Bioavailability and lack of toxicity of S-adenosyl-L-methionine (SAMe) in humans
JL Gören et al.
PHARMACOTHERAPY (2004)
SAMe use in children and adolescents
JL Schaller et al.
EUROPEAN CHILD & ADOLESCENT PSYCHIATRY (2004)
Vitamin B12, folate, and homocysteine in depression:: The Rotterdam study
H Tiemeier et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
Activation and induction of glycine N-methyltransferase by retinoids are tissue- and gender-specific
MH McMullen et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2002)
分享论文
